欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

全球仿制药市场报告(2016-2020年)

Global Generic Drugs Market 2016-2020

加工时间:2016-07-13 信息来源:EMIS 索取原文[111 页]
关键词:仿制药;剂型;效力;路线行政;质量;专利品牌药用途
摘 要:Generic drugs have the same chemical formula, dosage form, potency, route of administration, quality, and intended use as that of patented branded drugs. They cost 80%-85% lesser than their branded counterparts and are available soon after the patent expiries of original drugs. However, they are similar to original drugs in terms of safety, quality, and effectiveness. Manufacturers need to apply for an Abbreviated New Drug Application (ANDA) approval to receive approval of generics.
目 录:

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Overview of generics

Generic drugs industry

Comparison between generic drugs and branded

drugs

PART 06: Key leading countries

US

China

India

PART 07: Global pharmaceutical market

Market overview

Market size and forecast

PART 08: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 09: Market segmentation by category

Simple generics

Super generics

Biosimilars

PART 10: Market segmentation by therapeutic

application

PART 11: Geographical segmentation

Global generic drugs market by geographical

segmentation 2015-2020

Generic drugs market in Americas

Generic drugs market in APAC

Generic drugs market in EMEA

PART 12: Market drivers

Patent expiry of top-selling drugs

Growing acceptance of generic medicines

Increasing demand in emerging markets

Social and private health insurance in emerging

markets

Increasing prevalence of diseases

PART 13: Impact of drivers

PART 14: Market challenges

Adverse effects

Stringent regulations

Threat of counterfeit drugs

Intense competition among vendors

PART 15: Impact of drivers and challenges

PART 16: Market trends

M&A

Outsourcing of drug development

Strategic alliances

PART 17: Vendor landscape

Competitive scenario

Market share analysis 2015

Teva Pharmaceuticals

Sandoz

Allergan

Mylan

Sun Pharmaceuticals

STADA Arzneimittel

Other prominent vendors

PART 18: Appendix

List of abbreviations

PART 19: Explore Technavio

© 2016 武汉世讯达文化传播有限责任公司 版权所有 技术支持:武汉中网维优
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服